XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.19.2

Legal Settlements and Loss Contingencies | 6 Months Ended
--- | ---
Jun. 30, 2019
Legal Settlements and Loss Contingencies | NOTE 15 – Legal settlements and loss contingencies: In the second quarter of 2019, Teva recorded an expense of $646 million in legal settlements and loss contingencies , compared to $20 million in the second quarter of 2018. The expense in the second quarter of 2019 was mainly related to the $85 million settlement paid in the opioid litigation brought by the Oklahoma Attorney General and an estimated provision made for certain other opioid cases. In the first six months of 2019 , Teva recorded an expense of $703 million in legal settlements and loss contingencies , compared to income of $1,258 million in the first six months of 2018. The expense in the first six months of 2019 was mainly related to the $85 million settlement paid in the opioid litigation brought by the Oklahoma Attorney General and an estimated provision made for certain other opioid cases . As of June 30, 2019 and December 31, 2018, Teva’s provision for legal settlements and loss contingencies recorded under accrued expenses was $1,149 million and $562 million, respectively.

X
- Definition The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -URI http://asc.fasb.org/topic&trid=2127136 + Details
Name: | us-gaap_LegalMattersAndContingenciesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration